Global Group ACYW135 Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2024-2030
Page: 133
Published Date: 13 Feb 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Group ACYW135 Meningococcal Polysaccharide Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report studies the global Group ACYW135 Meningococcal Polysaccharide Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Group ACYW135 Meningococcal Polysaccharide Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Group ACYW135 Meningococcal Polysaccharide Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Group ACYW135 Meningococcal Polysaccharide Vaccine total production and demand, 2019-2030, (K Units)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine total production value, 2019-2030, (USD Million)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine domestic production, consumption, key domestic manufacturers and share
Global Group ACYW135 Meningococcal Polysaccharide Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Group ACYW135 Meningococcal Polysaccharide Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi-Pasteur, Walvax Biotechnology, Chengdu Kanghua Biological Products Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd, Zhejiang Tianyuan Biopharmaceutical Co., Ltd, Beijing Institute of Biological Products Co., Ltd, CanSino Biologics AG, Yuxi Watson Biotechnology Co., Ltd and Hualan Biovaccine Co., Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Group ACYW135 Meningococcal Polysaccharide Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market, Segmentation by Type
Class I Vaccines
Class II Vaccines
Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market, Segmentation by Application
Hospital
Clinic
Companies Profiled:
Sanofi-Pasteur
Walvax Biotechnology
Chengdu Kanghua Biological Products Co., Ltd
Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
Zhejiang Tianyuan Biopharmaceutical Co., Ltd
Beijing Institute of Biological Products Co., Ltd
CanSino Biologics AG
Yuxi Watson Biotechnology Co., Ltd
Hualan Biovaccine Co., Ltd
Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
Key Questions Answered
1. How big is the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
2. What is the demand of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
3. What is the year over year growth of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
4. What is the production and production value of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
5. Who are the key producers in the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
Table of Contents
1 Supply Summary
1.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Introduction
1.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Supply & Forecast
1.2.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value (2019 & 2023 & 2030)
1.2.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2030)
1.2.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Pricing Trends (2019-2030)
1.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Region (Based on Production Site)
1.3.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Region (2019-2030)
1.3.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Region (2019-2030)
1.3.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Region (2019-2030)
1.3.4 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2030)
1.3.5 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2030)
1.3.6 China Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2030)
1.3.7 Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Major Market Trends
2.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Demand (2019-2030)
2.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption by Region
2.2.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption by Region (2019-2024)
2.2.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2025-2030)
2.3 United States Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030)
2.4 China Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030)
2.5 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030)
2.6 Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030)
2.7 South Korea Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030)
2.8 ASEAN Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030)
2.9 India Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030)
3.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2019-2024)
3.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Manufacturer (2019-2024)
3.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024)
3.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Group ACYW135 Meningococcal Polysaccharide Vaccine in 2023
3.5.3 Global Concentration Ratios (CR8) for Group ACYW135 Meningococcal Polysaccharide Vaccine in 2023
3.6 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
3.6.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Region Footprint
3.6.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
3.6.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Comparison
4.1.1 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Comparison
4.2.1 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Comparison
4.3.1 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value (2019-2024)
4.4.3 United States Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2024)
4.5 China Based Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers and Market Share
4.5.1 China Based Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value (2019-2024)
4.5.3 China Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2024)
4.6 Rest of World Based Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2024)
5.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Class I Vaccines
5.2.2 Class II Vaccines
5.3 Market Segment by Type
5.3.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Type (2019-2030)
5.3.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type (2019-2030)
5.3.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2030)
6.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Application (2019-2030)
6.3.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application (2019-2030)
6.3.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2030)
7.1 Sanofi-Pasteur
7.1.1 Sanofi-Pasteur Details
7.1.2 Sanofi-Pasteur Major Business
7.1.3 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.1.4 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Sanofi-Pasteur Recent Developments/Updates
7.1.6 Sanofi-Pasteur Competitive Strengths & Weaknesses
7.2 Walvax Biotechnology
7.2.1 Walvax Biotechnology Details
7.2.2 Walvax Biotechnology Major Business
7.2.3 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.2.4 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Walvax Biotechnology Recent Developments/Updates
7.2.6 Walvax Biotechnology Competitive Strengths & Weaknesses
7.3 Chengdu Kanghua Biological Products Co., Ltd
7.3.1 Chengdu Kanghua Biological Products Co., Ltd Details
7.3.2 Chengdu Kanghua Biological Products Co., Ltd Major Business
7.3.3 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.3.4 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
7.3.6 Chengdu Kanghua Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
7.4.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Details
7.4.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Major Business
7.4.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.4.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
7.4.6 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd
7.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Details
7.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Major Business
7.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments/Updates
7.5.6 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.6 Beijing Institute of Biological Products Co., Ltd
7.6.1 Beijing Institute of Biological Products Co., Ltd Details
7.6.2 Beijing Institute of Biological Products Co., Ltd Major Business
7.6.3 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.6.4 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
7.6.6 Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.7 CanSino Biologics AG
7.7.1 CanSino Biologics AG Details
7.7.2 CanSino Biologics AG Major Business
7.7.3 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.7.4 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 CanSino Biologics AG Recent Developments/Updates
7.7.6 CanSino Biologics AG Competitive Strengths & Weaknesses
7.8 Yuxi Watson Biotechnology Co., Ltd
7.8.1 Yuxi Watson Biotechnology Co., Ltd Details
7.8.2 Yuxi Watson Biotechnology Co., Ltd Major Business
7.8.3 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.8.4 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
7.8.6 Yuxi Watson Biotechnology Co., Ltd Competitive Strengths & Weaknesses
7.9 Hualan Biovaccine Co., Ltd
7.9.1 Hualan Biovaccine Co., Ltd Details
7.9.2 Hualan Biovaccine Co., Ltd Major Business
7.9.3 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.9.4 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Hualan Biovaccine Co., Ltd Recent Developments/Updates
7.9.6 Hualan Biovaccine Co., Ltd Competitive Strengths & Weaknesses
7.10 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
7.10.1 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Details
7.10.2 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Major Business
7.10.3 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.10.4 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Developments/Updates
7.10.6 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Competitive Strengths & Weaknesses
8.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Chain
8.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Upstream Analysis
8.2.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Group ACYW135 Meningococcal Polysaccharide Vaccine Production Mode
8.6 Group ACYW135 Meningococcal Polysaccharide Vaccine Procurement Model
8.7 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Sales Model and Sales Channels
8.7.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Model
8.7.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Region (2019-2024) & (USD Million)
Table 3. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Region (2025-2030) & (USD Million)
Table 4. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2019-2024)
Table 5. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2025-2030)
Table 6. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Region (2019-2024) & (K Units)
Table 7. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Region (2025-2030) & (K Units)
Table 8. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Region (2019-2024)
Table 9. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Region (2025-2030)
Table 10. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Group ACYW135 Meningococcal Polysaccharide Vaccine Major Market Trends
Table 13. World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption by Region (2019-2024) & (K Units)
Table 15. World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Group ACYW135 Meningococcal Polysaccharide Vaccine Producers in 2023
Table 18. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Group ACYW135 Meningococcal Polysaccharide Vaccine Producers in 2023
Table 20. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
Table 22. World Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Group ACYW135 Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
Table 24. Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
Table 25. Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
Table 26. Group ACYW135 Meningococcal Polysaccharide Vaccine Competitive Factors
Table 27. Group ACYW135 Meningococcal Polysaccharide Vaccine New Entrant and Capacity Expansion Plans
Table 28. Group ACYW135 Meningococcal Polysaccharide Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share (2019-2024)
Table 37. China Based Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share (2019-2024)
Table 42. Rest of World Based Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share (2019-2024)
Table 47. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Type (2019-2024) & (K Units)
Table 49. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Type (2025-2030) & (K Units)
Table 50. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type (2019-2024) & (USD Million)
Table 51. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type (2025-2030) & (USD Million)
Table 52. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Application (2019-2024) & (K Units)
Table 56. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Application (2025-2030) & (K Units)
Table 57. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application (2019-2024) & (USD Million)
Table 58. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application (2025-2030) & (USD Million)
Table 59. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi-Pasteur Major Business
Table 63. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 64. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Sanofi-Pasteur Recent Developments/Updates
Table 66. Sanofi-Pasteur Competitive Strengths & Weaknesses
Table 67. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 68. Walvax Biotechnology Major Business
Table 69. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 70. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Walvax Biotechnology Recent Developments/Updates
Table 72. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 73. Chengdu Kanghua Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Chengdu Kanghua Biological Products Co., Ltd Major Business
Table 75. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 76. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
Table 78. Chengdu Kanghua Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 79. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Major Business
Table 81. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 82. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 84. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 85. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Major Business
Table 87. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 88. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 90. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 91. Beijing Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Beijing Institute of Biological Products Co., Ltd Major Business
Table 93. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 94. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 96. Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 97. CanSino Biologics AG Basic Information, Manufacturing Base and Competitors
Table 98. CanSino Biologics AG Major Business
Table 99. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 100. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. CanSino Biologics AG Recent Developments/Updates
Table 102. CanSino Biologics AG Competitive Strengths & Weaknesses
Table 103. Yuxi Watson Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Yuxi Watson Biotechnology Co., Ltd Major Business
Table 105. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 106. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
Table 108. Yuxi Watson Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 109. Hualan Biovaccine Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Hualan Biovaccine Co., Ltd Major Business
Table 111. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 112. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Hualan Biovaccine Co., Ltd Recent Developments/Updates
Table 114. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 115. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Major Business
Table 116. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 117. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 118. Global Key Players of Group ACYW135 Meningococcal Polysaccharide Vaccine Upstream (Raw Materials)
Table 119. Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Customers
Table 120. Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Distributors
List of Figure
Figure 1. Group ACYW135 Meningococcal Polysaccharide Vaccine Picture
Figure 2. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2030) & (K Units)
Figure 5. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price (2019-2030) & (US$/Unit)
Figure 6. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2019-2030)
Figure 7. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Region (2019-2030)
Figure 8. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2030) & (K Units)
Figure 9. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2030) & (K Units)
Figure 10. China Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2030) & (K Units)
Figure 11. Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2019-2030) & (K Units)
Figure 12. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (K Units)
Figure 15. World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Market Share by Region (2019-2030)
Figure 16. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (K Units)
Figure 17. China Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (K Units)
Figure 18. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (K Units)
Figure 19. Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (K Units)
Figure 20. South Korea Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (K Units)
Figure 22. India Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Group ACYW135 Meningococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Group ACYW135 Meningococcal Polysaccharide Vaccine Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Group ACYW135 Meningococcal Polysaccharide Vaccine Markets in 2023
Figure 26. United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share 2023
Figure 30. China Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share 2023
Figure 32. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Type in 2023
Figure 34. Class I Vaccines
Figure 35. Class II Vaccines
Figure 36. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Type (2019-2030)
Figure 37. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Type (2019-2030)
Figure 38. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Application in 2023
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Application (2019-2030)
Figure 44. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Application (2019-2030)
Figure 45. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2030) & (US$/Unit)
Figure 46. Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Chain
Figure 47. Group ACYW135 Meningococcal Polysaccharide Vaccine Procurement Model
Figure 48. Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Model
Figure 49. Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sanofi-Pasteur Walvax Biotechnology Chengdu Kanghua Biological Products Co., Ltd Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Zhejiang Tianyuan Biopharmaceutical Co., Ltd Beijing Institute of Biological Products Co., Ltd CanSino Biologics AG Yuxi Watson Biotechnology Co., Ltd Hualan Biovaccine Co., Ltd Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
Related Reports
15 Feb 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
